Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00NWV
|
|||
| Former ID |
DIB001225
|
|||
| Drug Name |
Ypeginterferon alfa-2a
|
|||
| Synonyms |
Ypeginterferon alfa-2a (chronic hepatitis B) Amoytop; Ypeginterferon alfa-2a (chronic hepatitis C) Amoytop; YPEG-rhIFNalpha-2a (chronic hepatitis B/chronic hepatitis C infection), Amoytop
Click to Show/Hide
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Phase 3 | [1] | |
| Company |
Xiamen Amoytop Biotech Co Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01581398) Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.